Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Significantly expands cell and gene therapy capabilities and offerings.
July 2, 2021
By: Kristin Brooks
AGC Biologics, a CDMO, signed a purchase agreement for Novartis’ state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, CO. The facility provides AGC with significant additional capacity and space to expand its end-to-end Cell and Gene Therapy (C>) offering, ensuring security of supply for current and future C> customers. This facility is only 16 miles from AGC’s state-of-the-art large-scale stainless steel mammalian facility in Boulder, CO. This news follows an expansion at its Center of Excellence for Cell and Gene Therapy in Milan, Italy. AGC has invested heavily in C> services since the acquisition and integration of MolMed in 2020, and is now one of the few CDMO’s in the world offering end-to-end C> services, including plasmid production of all grades. The Longmont facility adds 622,000 sq.-ft. of operations and office space within six buildings on the 229-acre overall campus, located 40 minutes north of Denver. AGC Biologics aims to hire a significant percentage of the talented staff employed by Novartis at the facility. “The Longmont facility fits perfectly into AGC’s long-term growth and expansion plans,” said AGC Biologics Chief Executive Officer, Patricio Massera. “This move is driven by our dedication to satisfy the needs of our current and future customers.” “Adding this facility into our global network will be one more step towards our vision of being able to offer our partners, whatever they need it, wherever they need it,” said AGC Biologics Chief Business Officer, Mark Womack.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !